Almac Group is a privately owned, global contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors. Headquartered in Craigavon, Northern Ireland, the company provides integrated services spanning drug discovery, development, clinical trial supply, and commercial manufacturing and packaging.
Through divisions including Almac Sciences, Arran Chemical Company, Almac Pharma Services, Almac Clinical Services, and Almac Diagnostic Services, the Group offers capabilities relevant to the chemical industry such as small‑molecule API development and GMP manufacture, custom synthesis of fine chemicals and intermediates, chiral chemistry and biocatalysis, peptide chemistry, solid‑state and analytical services, formulation, and secondary packaging. Almac operates a global network of facilities across the UK, Ireland, North America, and Asia, supporting projects from early phase through to commercial supply under international regulatory standards.